Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis

@article{SheikhTaha2017PulmonaryNB,
  title={Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis},
  author={M. Sheikh-Taha and L. Corman},
  journal={Multiple Sclerosis Journal},
  year={2017},
  volume={23},
  pages={872 - 874}
}
Nocardia is a Gram-positive aerobic pathogen that usually affects immunocompromised patients. We report a case of pulmonary infection caused by a rare Nocardia species, Nocardia beijingensis, in a 50-year-old woman who had received alemtuzumab for the treatment of her multiple sclerosis. The invasive pulmonary infection was successfully treated with meropenem. 
27 Citations
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis
  • 29
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance
  • 10
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
  • 31
  • PDF
Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications
  • PDF
...
1
2
3
...

References

SHOWING 1-10 OF 11 REFERENCES
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
  • 57
  • PDF
Alemtuzumab for the treatment of multiple sclerosis
  • 11
  • PDF
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
  • A. Peleg, S. Husain, +10 authors D. Paterson
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2007
  • 229
  • PDF
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
  • 262
  • PDF
On behalf of the CAMMS223 study group. Descriptive analysis of infectious adverse events in alemtuzumab-treated multiple sclerosis patients
  • Proceedings of the 25th congress of the European committee for treatment and research in multiple sclerosis,
  • 2009
...
1
2
...